• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

己酮可可碱可增加脑血管疾病患者的脑血流量。

Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease.

作者信息

Bowton D L, Stump D A, Prough D S, Toole J F, Lefkowitz D S, Coker L

机构信息

Department of Anesthesia (Critical Care), Wake Forest University Medical Center, Winston-Salem, North Carolina.

出版信息

Stroke. 1989 Dec;20(12):1662-6. doi: 10.1161/01.str.20.12.1662.

DOI:10.1161/01.str.20.12.1662
PMID:2512690
Abstract

We determined the immediate effects of pentoxifylline on cerebral blood flow in 10 patients with cerebrovascular disease; four received 400 mg and six received 800 mg pentoxifylline orally. Regional cerebral blood flow was measured before (baseline) and 2, 4, and 6 hours after pentoxifylline administration using the xenon-133 clearance technique with 16 detectors (eight per hemisphere). Global cerebral blood flow as a percentage of the baseline value increased significantly after 800 mg but not 400 mg pentoxifylline (p = 0.017 and p = 0.29, respectively). Regional cerebral blood flow as a percentage of the baseline value at the detector with the lowest baseline value increased significantly 2 hours after both 400 mg and 800 mg pentoxifylline (p = 0.038 and p = 0.010, respectively). Cerebrovascular reactivity to carbon dioxide was preserved despite the increases in cerebral blood flow. Pentoxifylline increases cerebral blood flow and is not associated with "intracerebral steal" in patients with cerebrovascular disease.

摘要

我们测定了己酮可可碱对10例脑血管疾病患者脑血流量的即时影响;4例口服400毫克己酮可可碱,6例口服800毫克己酮可可碱。使用带有16个探测器(每侧半球8个)的氙-133清除技术,在服用己酮可可碱前(基线)以及服用后2、4和6小时测量局部脑血流量。800毫克己酮可可碱后,全脑血流量占基线值的百分比显著增加,而400毫克己酮可可碱后则未增加(分别为p = 0.017和p = 0.29)。在基线值最低的探测器处,400毫克和800毫克己酮可可碱后2小时,局部脑血流量占基线值的百分比均显著增加(分别为p = 0.038和p = 0.010)。尽管脑血流量增加,但对二氧化碳的脑血管反应性仍得以保留。己酮可可碱可增加脑血管疾病患者的脑血流量,且与“脑内窃血”无关。

相似文献

1
Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease.己酮可可碱可增加脑血管疾病患者的脑血流量。
Stroke. 1989 Dec;20(12):1662-6. doi: 10.1161/01.str.20.12.1662.
2
Effect of pentoxifylline on cerebral blood flow in patients with chronic cerebrovascular disease.己酮可可碱对慢性脑血管病患者脑血流量的影响。
J Int Med Res. 1981;9(3):211-4. doi: 10.1177/030006058100900311.
3
Effect of pentoxifylline on regional cerebral blood flow in patients with cerebral vascular disorders.己酮可可碱对脑血管疾病患者局部脑血流量的影响。
Eur Neurol. 1983;22 Suppl 1:108-15. doi: 10.1159/000115659.
4
A controlled study on the effect of pentoxifylline and an ergot alkaloid derivative on regional cerebral blood flow in patients with chronic cerebrovascular disease.
Angiology. 1988 May;39(5):449-57. doi: 10.1177/000331978803900507.
5
Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease.己酮可可碱对脑血管疾病患者局部脑血流的影响。
Pharmatherapeutica. 1981;2(8):528-31.
6
Comparative randomized study of cerebral blood flow after long-term administration of pentoxifylline and co-dergocrine mesylate in patients with chronic cerebrovascular disease.
Curr Med Res Opin. 1985;9(7):475-9. doi: 10.1185/03007998509109621.
7
The effect of pentoxifylline ('Trental') on cerebral blood flow: a double-blind study.己酮可可碱(“曲克芦丁”)对脑血流量的影响:一项双盲研究。
Curr Med Res Opin. 1976;4(10):681-7. doi: 10.1185/03007997609112002.
8
Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline.
Curr Med Res Opin. 1981;7(4):253-63. doi: 10.1185/03007998109114271.
9
Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline.脑血管疾病患者的脑血流量:己酮可可碱研究
Ric Clin Lab. 1981;11 Suppl 1:243-6.
10
Measurement of cerebral blood flow following intravenous administration of pentoxifyline ('Trentral').静脉注射己酮可可碱(“曲克芦丁”)后脑血流量的测量。
Curr Med Res Opin. 1977;4(7):521-8. doi: 10.1185/03007997709109343.

引用本文的文献

1
Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial.己酮可可碱辅助利培酮治疗稳定型精神分裂症阴性症状:一项随机、双盲、安慰剂对照试验
Int J Neuropsychopharmacol. 2024 Dec 28;28(1). doi: 10.1093/ijnp/pyae051.
2
Hemorheological, cardiorespiratory, and cerebrovascular effects of pentoxifylline following acclimatization to 3,800 m.适应 3800 米海拔高度后己酮可可碱对血液流变学、心肺和脑血管的影响。
Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H705-H714. doi: 10.1152/ajpheart.00783.2023. Epub 2024 Jan 19.
3
Vancomycin Is Protective in a Neonatal Mouse Model of -Potentiated Hypoxic-Ischemic Brain Injury.
万古霉素在 - 增强型缺氧缺血性脑损伤新生小鼠模型中具有保护作用。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.02003-19.
4
Pentoxifylline for vascular health: a brief review of the literature.己酮可可碱对血管健康的作用:文献综述
Open Heart. 2016 Feb 8;3(1):e000365. doi: 10.1136/openhrt-2015-000365. eCollection 2016.
5
Pentoxifylline attenuates ischemia/reperfusion injury to the small intestine in the rat.己酮可可碱减轻大鼠小肠缺血/再灌注损伤。
Pediatr Surg Int. 1996 Jun;11(5-6):329-33. doi: 10.1007/BF00497805. Epub 2013 Sep 21.
6
Pentoxifylline reduces chronic post-ischaemia pain by alleviating microvascular dysfunction.己酮可可碱通过减轻微血管功能障碍来减轻慢性缺血后疼痛。
Eur J Pain. 2014 Mar;18(3):406-14. doi: 10.1002/j.1532-2149.2013.00381.x. Epub 2013 Jul 31.
7
Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.己酮可可碱治疗心血管疾病的潜在疗效。
Exp Clin Cardiol. 2004 Summer;9(2):103-11.
8
Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.己酮可可碱(氧代己酮可可碱)。对其治疗外周血管疾病和脑血管疾病疗效的综述。
Drugs Aging. 1995 Dec;7(6):480-503. doi: 10.2165/00002512-199507060-00007.